PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT o 2.1 Preface o 2.2 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE o Market ecosystem o Market characteristics o Value Chain Analysis o Market segmentation analysis PART 04: MARKET SIZING o Market definition o Market sizing 2019 o Market size and forecast 2019-2024 o Market Outlook PART 05: FIVE FORCES ANALYSIS o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition PART 06: MARKET SEGMENTATION BY PRODUCT o Market segmentation by product o Comparison by product o Soft-tissue attachments - Market size and forecast 2019-2024 o Hemostatic agents - Market size and forecast 2019-2024 o Bone graft substitutes - Market size and forecast 2019-2024 o Surgical sealants and adhesives - Market size and forecast 2019-2024 o Adhesion barriers - Market size and forecast 2019-2024 o Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2019-2024 o Europe - Market size and forecast 2019-2024 o Asia - Market size and forecast 2019-2024 o ROW - Market size and forecast 2019-2024 o Key leading countries o Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES o Market drivers o Market challenges PART 11: MARKET TRENDS o Technological advances o Enhanced pipeline products o Funding for the development of innovative products PART 12: VENDOR LANDSCAPE o Overview o Landscape disruption o Competitive scenario PART 13: VENDOR ANALYSIS o Vendors covered o Vendor classification o Market positioning of vendors o B. Braun Melsungen AG o Baxter International Inc. o Becton, Dickinson and Co. o CSL Ltd. o Getinge AB o Integra LifeSciences Holdings Corp. o Johnson & Johnson o Medtronic Plc o Pfizer Inc. o Stryker Corp. PART 14: APPENDIX o Research methodology o List of abbreviations o Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO Exhibit 01: Global healthcare supplies market Exhibit 02: Segments of global healthcare supplies market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Vendors: Key offerings Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2019 Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions) Exhibit 09: Global market: Year-over-year growth 2020-2024 (%) Exhibit 10: Five forces analysis 2019 Exhibit 11: Five forces analysis 2024 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2019 Exhibit 18: Product - Market share 2019-2024 (%) Exhibit 19: Comparison by product Exhibit 20: Soft-tissue attachments - Market size and forecast 2019-2024 ($ millions) Exhibit 21: Soft-tissue attachments - Year-over-year growth 2020-2024 (%) Exhibit 22: Hemostatic agents - Market size and forecast 2019-2024 ($ millions) Exhibit 23: Hemostatic agents - Year-over-year growth 2020-2024 (%) Exhibit 24: Bone graft substitutes - Market size and forecast 2019-2024 ($ millions) Exhibit 25: Bone graft substitutes - Year-over-year growth 2020-2024 (%) Exhibit 26: Surgical sealants and adhesives - Market size and forecast 2019-2024 ($ millions) Exhibit 27: Surgical sealants and adhesives - Year-over-year growth 2020-2024 (%) Exhibit 28: Adhesion barriers - Market size and forecast 2019-2024 ($ millions) Exhibit 29: Adhesion barriers - Year-over-year growth 2020-2024 (%) Exhibit 30: Market opportunity by product Exhibit 31: Customer landscape Exhibit 32: Market share by geography 2019-2024 (%) Exhibit 33: Geographic comparison Exhibit 34: North America - Market size and forecast 2019-2024 ($ millions) Exhibit 35: Number of surgical procedures in 2014: US Exhibit 36: US: percentage of surgical visits in ambulatory and inpatient settings (2014) Exhibit 37: North America - Year-over-year growth 2020-2024 (%) Exhibit 38: Europe - Market size and forecast 2019-2024 ($ millions) Exhibit 39: Exhibit:  Europe: Surgical procedures related to circulatory system diseases (2017) Exhibit 40: Europe - Year-over-year growth 2020-2024 (%) Exhibit 41: Asia - Market size and forecast 2019-2024 ($ millions) Exhibit 42: Asia - Year-over-year growth 2020-2024 (%) Exhibit 43: ROW - Market size and forecast 2019-2024 ($ millions) Exhibit 44: ROW - Year-over-year growth 2020-2024 (%) Exhibit 45: Key leading countries Exhibit 46: Market opportunity Exhibit 47: US: Inpatient stays in 2014 for operating room procedures for cardiovascular and orthopedic related            disorders Exhibit 48: Product launch details and market impact analysis Exhibit 49: Acquisitions and their market impact analysis Exhibit 50: Product recalls Exhibit 51: Impact of drivers and challenges Exhibit 52: Vendor landscape Exhibit 53: Landscape disruption Exhibit 54: Vendors covered Exhibit 55: Vendor classification Exhibit 56: Market positioning of vendors Exhibit 57: B. Braun Melsungen AG - Vendor overview Exhibit 58: B. Braun Melsungen AG - Business segments Exhibit 59: B. Braun Melsungen AG - Organizational developments Exhibit 60: B. Braun Melsungen AG - Geographic focus Exhibit 61: B. Braun Melsungen AG - Segment focus Exhibit 62: B. Braun Melsungen AG - Key offerings Exhibit 63: B. Braun Melsungen AG - Key customers Exhibit 64: Baxter International Inc. - Vendor overview Exhibit 65: Baxter International Inc. - Product segments Exhibit 66: Baxter International Inc. - Organizational developments Exhibit 67: Baxter International Inc. - Geographic focus Exhibit 68: Baxter International Inc. - Segment focus Exhibit 69: Baxter International Inc. - Key offerings Exhibit 70: Baxter International Inc. - Key customers Exhibit 71: Becton, Dickinson and Co. - Vendor overview Exhibit 72: Becton, Dickinson and Co. - Business segments Exhibit 73: Becton, Dickinson and Co. - Organizational developments Exhibit 74: Becton, Dickinson and Co. - Geographic focus Exhibit 75: Becton, Dickinson and Co. - Segment focus Exhibit 76: Becton, Dickinson and Co. - Key offerings Exhibit 77: Becton, Dickinson and Co. - Key customers Exhibit 78: CSL Ltd. - Vendor overview Exhibit 79: CSL Ltd. - Business segments Exhibit 80: CSL Ltd. - Organizational developments Exhibit 81: CSL Ltd. - Geographic focus Exhibit 82: CSL Ltd. - Segment focus Exhibit 83: CSL Ltd. - Key offerings Exhibit 84: CSL Ltd. - Key customers Exhibit 85: Getinge AB - Vendor overview Exhibit 86: Getinge AB - Business segments Exhibit 87: Getinge AB - Organizational developments Exhibit 88: Getinge AB - Geographic focus Exhibit 89: Getinge AB - Segment focus Exhibit 90: Getinge AB - Key offerings Exhibit 91: Getinge AB - Key customers Exhibit 92: Integra LifeSciences Holdings Corp. - Vendor overview Exhibit 93: Integra LifeSciences Holdings Corp. - Business segments Exhibit 94: Integra LifeSciences Holdings Corp. - Organizational developments Exhibit 95: Integra LifeSciences Holdings Corp. - Geographic focus Exhibit 96: Integra LifeSciences Holdings Corp. - Segment focus Exhibit 97: Integra LifeSciences Holdings Corp. - Key offerings Exhibit 98: Integra LifeSciences Holdings Corp. - Key customers Exhibit 99: Johnson & Johnson - Vendor overview Exhibit 100: Johnson & Johnson - Business segments Exhibit 101: Johnson & Johnson - Organizational developments Exhibit 102: Johnson & Johnson - Geographic focus Exhibit 103: Johnson & Johnson - Segment focus Exhibit 104: Johnson & Johnson - Key offerings Exhibit 105: Johnson & Johnson - Key customers Exhibit 106: Medtronic Plc - Vendor overview Exhibit 107: Medtronic Plc - Business segments Exhibit 108: Medtronic Plc - Organizational developments Exhibit 109: Medtronic Plc - Geographic focus Exhibit 110: Medtronic Plc - Segment focus Exhibit 111: Medtronic Plc - Key offerings Exhibit 112: Medtronic Plc - Key customers Exhibit 113: Pfizer Inc. - Vendor overview Exhibit 114: Pfizer Inc. - Business segments Exhibit 115: Pfizer Inc. - Organizational developments Exhibit 116: Pfizer Inc. - Geographic focus Exhibit 117: Pfizer Inc. - Segment focus Exhibit 118: Pfizer Inc. - Key offerings Exhibit 119: Pfizer Inc. - Key customers Exhibit 120: Stryker Corp. - Vendor overview Exhibit 121: Stryker Corp. - Business segments Exhibit 122: Stryker Corp. - Organizational developments Exhibit 123: Stryker Corp. - Geographic focus Exhibit 124: Stryker Corp. - Segment focus Exhibit 125: Stryker Corp. - Key offerings Exhibit 126: Stryker Corp. - Key customers Exhibit 127: Validation techniques employed for market sizing Exhibit 128: Definition of market positioning of vendors  

B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Co., CSL Ltd., Getinge AB, Integra LifeSciences Holdings Corp., Johnson & Johnson, Medtronic Plc, Pfizer Inc., Stryker Corp.